FDA Inspection 1018321 — Akron General Medical Center Institutional Research Review Board
The FDA completed an inspection of Akron General Medical Center Institutional Research Review Board on July 13, 2017 in Akron, OH. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- July 13, 2017
- Fiscal Year
- 2017
- Product Type
- Devices
- Project Area
- Bioresearch Monitoring
- Location
- Akron, OH (United States)
Additional Details
IRB